Aspect Medical Systems was founded in 1987and is a provider of brain monitoring technologies. Aspect’s premier product — Bispectral Index (BIS™) technology —became the first clinically proven and commercially available direct measure of the effects of anesthetics and sedatives on the brain. At present an estimated 20 million patients undergo surgery with general anesthesia or deep sedation each year in the United States, and an additional 30 million in Europe and Japan. BIS technology allows medical professionals to reliably assess level of consciousness and customize the precise amount of drug required by each patient, resulting in better overall patient care and fewer undesirable events.
On September 28, 2009, Covidien (NYSE: COV) and Aspect Medical Systems, Inc. (NASDAQ: ASPM) today announced that Covidien has reached a definitive agreement to acquire Aspect, a global market leader in brain monitoring technology.
CSRHub includes data on climate change solutions, Community, International Integrated Reporting Council, long term investment, Philanthropy, and Sustainability.